Complete revascularization
Complete revascularization has been studied in 3 papers since 2025: 1 trial and 1 observational study in people, 1 review; 2 in the past year. The newest paper, Oct 31, 2026: “Secondary Cardiovascular Prevention After Coronary Heart Disease in a North African country: Findings From the NATURE STOP-CHD Tunisian National Registry”.
3 papers study it3 findingsUpdated
1 new paper in 30 daysSee all 3 papers on complete revascularization
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“Complete revascularization reduced the primary endpoint with no significant interaction between revascularization strategy and CFS category (p for interaction = 0.769).”
1 of its findings points the other way.
- 2 independent labs in 2 countries
- 1 finding against
- Funders: Sahajanand Medical Technologies and 1 more
- Human trial1
- Humans1
Studies in people
1 study gave complete revascularization to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases death, MI, stroke, or ischemia-driven revascularization | Randomized trial3 years | 1,010 people≥75 yearsOlder adults; older patients with MI and multivessel disease | Age and ageing, Mar 16, 2026 |
What did studies of complete revascularization find?
2Studies of complete revascularization measured 2 outcomes; the most studied are mortality (1 study) and death, MI, stroke, or ischemia-driven revascularization (1).
Mortality
no changein humans1downin humans1OR 1.03–1.75
1 study
Mortality
no changein humans1downin humans1OR 1.03–1.75
Complete revascularization showed no clear effect on mortality in humans (elderly patients with multivessel CAD presenting with STEMI) (OR 1.03, 95% CI 0.61-1.72; p = 0.92).
“there was no significant difference in risk of all-cause mortality with complete versus culprit-only revascularization in studies of only STEMI patients”
Reviewelderly patients with multivessel CAD presenting with STEMIn = 11,994
International journal of cardiology. Heart & vasculature
Complete revascularization decreases mortality in humans (elderly patients with multivessel CAD) (OR 1.75, 95% CI 1.40-2.18; p < 0.001).
“Patients who underwent complete revascularization had significantly lower all-cause and CV mortality compared to culprit-only revascularization”
Reviewelderly patients with multivessel CAD29.0 monthsn = 11,994
International journal of cardiology. Heart & vasculature
Death, MI, stroke, or ischemia-driven revascularization
downin humans1
1 study
Death, MI, stroke, or ischemia-driven revascularization
downin humans1
Complete revascularization decreases death, MI, stroke, or ischemia-driven revascularization in humans (older patients with MI and multivessel disease).
“Complete revascularization reduced the primary endpoint with no significant interaction between revascularization strategy and CFS category (p for interaction = 0.769).”
Human trialolder patients with MI and multivessel diseasen = 1,010
Age and ageing